Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
PZ HTL SA
GLOBETECH PUBLISHING LLC

Upgrades Enhance Dedicated Protein Purification System

By BiotechDaily International staff writers
Posted on 22 May 2013
A flexible and easily customizable protein purification system was designed to enable investigators to automate laborious and repetitive protein purification steps and allow them to concentrate on research applications of the purified sample.

The GE Healthcare (Uppsala, Sweden) ÄKTA Pure Protein Purification System is a flexible and intuitive chromatography platform for fast purification of proteins, peptides, and nucleic acids from microgram to gram levels of target product.

The latest generation of the ÄKTA Pure System boasts a new fraction collector that is covered to minimize contamination and supports flexible combinations of collection vessels from deep-well plates to 250 mL bottles.

In addition, a novel sample pump provides fast, automated, and complete loading of up to seven samples. The pump's integrated air-sensor detects the final drop of sample, automatically preventing the introduction of air while ensuring the complete sample reaches the column. The sample pump also has a robust wash program that removes any air introduced between samples.

The ÄKTA Pure Systems may be customized quickly and easily due to the modular design of both its hardware and software components. The operator is able to choose from more than 20 proven hardware options, and the system may be extended further by interfacing third-party add-ons such as detectors and autosamplers.

Related Links:

GE Healthcare



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: This novel, flexible film that can react to light is a promising step toward an artificial retina (Photo courtesy of the American Chemical Society).

Novel Nanofilm May Be Artificial Retina Precursor

Researchers have used advanced nanotechnology techniques to develop a light-sensitive film that has potential for future artificial retina applications. Investigators at the Hebrew University of Jerusalem... Read more

Drug Discovery

view channel
Image: Disruption and removal of malaria parasites by the experimental drug (+)-SJ733 (Photo courtesy of the University of California, San Francisco).

Experimental Antimalaria Drug Induces the Immune System to Destroy Infected Red Blood Cells

An experimental drug for the treatment of malaria was found to induce morphological changes in infected erythrocytes that enabled the immune system to recognize and eliminate them. Investigators at... Read more

Biochemistry

view channel

Blocking Enzyme Switch Turns Off Tumor Growth in T-Cell Acute Lymphoblastic Leukemia

Researchers recently reported that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia. An estimated 25% of the 500 US adolescents and young adults diagnosed yearly with this aggressive disease fail to respond to... Read more

Business

view channel

R&D Partnership Initiated to Reduce Development Time for New Drugs

nanoPET Pharma, GmbH (Berlin, Germany) signed an open-ended framework contract with the international pharmaceutical company Boehringer Ingelheim (Ridgefield, CT, USA). By developing customized contrast agents for research in both basic and preclinical studies, nanoPET Pharma will contribute to the enhancement of Boehringer... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.